Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have a feeling they will Put out the Biopsy PR during the Filming of the A&E episodes...which is happening this Month
Timing is everything ;]
Looks like I guessed the bottom but forgot to buy the last 2 prev. days... I hate chasing but If you read my other post yesterday I said 3.45 is the Piviot point and now the stocks breaking out. I nailed it perfectly except I did not buy yet and ticked at myself for not getting 3.15
I agree , I like when volume drops...only the strong are ready for the next spike and will make the most $$$$$$
I am relaxed and confident that the best has yet to come for CBIS stock ;]
http://apothecary-genetics.spruz.com/chemdawg.htm
So true thanks for posting , Looks like a green close coming today.
Sometimes I like it when volume drys up...it tells me all the flippers have moved on and strong hands are holding. The selling is starting to thin out and PPS will close green today .IMO
CBIS long
Looks like a - 71% decrease in CBIS shorts from Jan. to feb.
Looks like the shorts are hitting the EXIT and they are getting squeezed in the process.
This is all just another good sign we see .70 soon...
The latest PR was not Fluff, patient #3 case is one of the worst cases ever ...one Dr. even gave up on the guy ...the tumor was huge.
You expect everything to happen all at once .
You do not understand, nor do I care to educate you on how Medical break throughs like this work...It takes time.
same goes for Biopsy results for #2 I expect news by the end of this month ...Management will not Fail right now, contrary to what some bashers think about these "fluff PR's" is they are released to update investors and keep the daytraders interested...Management is playing this Perfectly.
Biopsy news is coming in 16 business days OR LESS so I do not concern myself with the swings lately...
The A & E show with Brett who is now an Employee of CBIS will get Huge public intrest in CBIS.The filiming is going on right now so this will be perfect timing to have this news released while the show is being filmed. They will have the news of one of CBIS pateints being cured and this stock will skyrocket.
And the more I check the news storys on MMJ Legalization...it looks like the Mainstream Public is Finnally shifting its decision when they go to Vote in November for Legaliztion.
latest poll has 62% Californians voting to Legalize...Yes the time is NOW to invest in CBIS !
If Legalized in some states it would put CBIS over 1.00
I know you gomez dont have the time nor the patience as I do so I wont explain the buy and hold method especially for a flipper. I know this is ihub and most here are flippers so take no offense its just not the way to make money when you have a stock like CBIS with as much potential as it does...JMHO
Yes really, You said the same thing at .03...some people never learn LOL
He's always wrong, notice how he was bashing when the stock was down this morning and now that its turned green his posts have gotten less bashy...
I think they start Phase 1 and after postive Trials in Thailand this Company could get bought out By a bigger Pharma Co. wanting to expand their pipeline with CBIS products.
What could be the buyout price ? Well I guess we could compare the deals GW pharma recieved from Otsuka.
Nice news...looks like we are about to go green ;]
Yhttp://apothecary-genetics.spruz.com/sour-grapes.htmes
looks like someone has sour grapes from selling to early.
Apothecary has the Kind
Yeah I'm doing it today....it has become a joke to have to put up with constant negativity. Even when the stock was Going up big everyday ..all I heard was the same old Blah blah...Been wrong since .03 and still wrong today.
King of Kush Brett Bogue
http://bigbudsmag.com/grow/article/king-kush-marijuana-july-2011
.18 no news
.34 Biopsy news
Looks like a bottom might have hit here with APRI.
It has bounced off this level twice looking at the Chart..
Once back in Aug. and again in Oct. bottoming at around 3.25
If the stock breaks 3.45 it could run...I want to get a taste of APRI again so I will be watching closely.
MPP is a Solid Organization, we must back these guys...they are on the front lines of the battle.
Join the ASA. I did today
http://www.safeaccessnow.org/
CBIS longs United
By Election time CBIS and other red hot MMJ stocks will have have tripled and quadrupled from the PPS today...
Especially CBIS way too much growth in this sector to not let this moment in time pass by.....
Just like the Old Goldrush 49er days...this is the new Century of MMJ "goldrush" get in on CBIS on the ground floor at the levels it trading at IMO. CBIS product Line will be growing...
Longs here will be rewarded for holding
He said " by the end of this month"
not at the end of this month...
news could hit before the bell tomorrow.
Rollitup
?Scientists have discovered that blocking a marijuana-like chemical in the brain drastically increases fat burn, allowing people (OK, in the study it was mice) to eat more and exercise less without gaining weight.
University of California Irvine pharmacology professor Daniele Piomelli and his colleagues found a way to breed mice who had naturally low levels of the endocannabinoid 2-AG, reports Dennis Romero at LA Weekly. "These modified mice ate more and moved less than typical mice, but did not gain any weight, even when they were fed a high-fat diet," the researchers noted.
Now, while that may sound as if a cannabinoid-blocking pill would allow you to eat all the junk food you want, not exercise, and still not gain any weight, you might wanna hold off just a minute before stocking your freezer with Klondike bars.
Previous research has found that endocannabinoids play an important role in regulating energy metabolism, reports Jennifer Walsh at the Huffington Post.
?A previous study by Piomelli found that these compounds make us crave fat, so he decided to see if lowering the levels of cannabinoids could have the opposite effect. He bred mice to produce only low levels of the compound, then compared their behavior and health with that of normal mice.
The modified stayed skinny even on a high-fat diet. They also had normal blood pressure and no increased risk of heart disease and diabetes that usually come with such a diet.
The researchers determined that the brown fat of the modified mice was overactive -- it was being turned into heat much quicker than in normal mice. Brown fat is a type of fat that keeps mammals warm, burning off excess energy.
"We discovered that these mice were resistant to obesity because they burned fat calories much more efficiently that normal mice do," Piomelli said. "We had know that endocannabinoids play a critical role in cell energy regulation, but this is the first time we found a target where this occurs."
But Wait A Minute...
While the study's results may have you thinking wonderful thoughts like "effortless dieting," there are a couple of snakes (aren't there always?) in this dietary Garden of Eden.
?For starters, as we already pointed out, the mice in the study, which was published in the March issue of Cell Metabolism, were bred to have low levels of the endocannabinoid 2-AG; a drug to actually block the effects of 2-AG in humans would take years to develop.
"To produce the desired effects, we would need to create a drug that blocks 2-AG production in the brain, something we're not yet able to do," Piomelli noted.
"So don't cancel that gym membership just yet," Piomelli said. "But as you hit the treadmill, think about the added health benefits if you could train your brain to make fewer endocannabinoids."
Secondly -- and this is important to point out, especially since apparently all of the mainstream media overlooked it -- cannabinoid blockers in the past have shown themselves to be quite dangerous, and in fact have resulted in suicidal behavior.
When the endocannabinoids have shown themselves to be crucial in the regulation of higher cognition, learning, memory, stress, pain, and appetite, to muck about in the brain willy-nilly by blocking their receptors seems a foolhardy premise indeed, akin to a bull in a china shop.
All the effects of endocannabinoids are not limited to the central nervous system -- peripheral tissues have receptors are are affected as well. Not all of these effects are known or understood, points out Corpus Callosum, therefore there are many potential adverse effects.
The infamous CB1 receptor blocker Rimonabant -- brand name Accomplia -- was the first selective cannabinoid receptor to be approved for use, after just two years of use (2006-2008), it was concluded by the European Medicines Agency (EMEA) that "the benefits of Accomplia no longer outweighed the risks, and subsequently recommended the product be suspended from the UK market."
Rimonabant was used for obesity and for smoking cessation (it also blocks the psychoactive effects of marijuana), with sales in the UK starting up in July 2006. It only took just over two years, until October 2008, for the EMEA to recommend that doctors not prescribe the drug "due to the risk of serious psychiatric problems and even suicide."
Shortly after its market introduction, press reports and independent studies suggested side effects occurred more intensely and more commonly that claimed by the manufacturer, the French pharma firm Sanofi-Aventis, in their clinical studies. Rimonabant's blocking of the CB1 cannabinoid receptors in the brain frequently resulted in severe depression and suicidal thoughts.
Additionally, research which was released late last year suggests that deficits in endocannabinoids may contribute to anorexia nervosa and bulimia.
In that study, scientists measure the status of the endocannabinoid system indirectly by finding whether there was an increase or decrease in the density of CB1 endocannabinoid receptors. They compared these densities in women with anorexia or bulimia with those of healthy women.
Researchers found evidence of deficits in endocannabinoid levels or reduced CB1 receptor function in the brains of women with anorexia nervosa. CB1 receptor availability in then insula (a region that integrates body perception, reward and emotion, functions known to be disturbed in these patients) was affected in both anorexia and bulimia patients.
Researchers hope those findings lead to a new target for developing drugs to treat eating disorders, a practice currently being investigated with animal test subjects.
NICE !!!!! thanks for Posting...LEAK it out lol
Bye Bye...come back for a visit when we are over .30 before the month is over.
Only the strong will make money here!
One of these days we will here from someone like Otsuka to develop the CBIS Extracts in trials for the FDA...
The Partner deal will be worth millions ! Otsuka gave up 18 million for the rights to Sativex.
We are sitting on a Goldmine
Nice find...GO CBIS
"this set of deals is designed to bring new products, revenues, and EXCUTIVE MANAGEMENT to the companys growing operations"
DENVER--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS.ob), a pioneering US biotech company developing pharmaceutical cannabis products, is pleased to announce final negotiations to target an immediate European expansion with opportune acquisitions & licensing deals. This new set of deals is designed to bring to bring new products, revenues, and executive management to the company’s growing operations. The target European company has already created its footprint distributing its products in the European Markets and around the world while meeting Cannabis Science’s standards to ensure the utmost quality control and stringent procedures.
This potential acquisition will give Cannabis Science additional products and revenues along with some outstanding continued growth with a good mix of all three product lines and Cannabis Science formulations in Europe and around the world. Continuing in the current focus with the FDA, OTC markets and dispensaries, the Company expects to expand all its current formulations along with the new European line of products the Company is negotiating to purchase. These new European resources will enhance our internal operations and are a vital piece of fulfilling our business model to bring our full line of both Cannabis Science Brand pharmaceutical and over the counter products to Europe. This acquisition can give Cannabis Science additional resources needed for global distribution channels for their products as well as expanding the market potential for the new European line to be acquired.
Looking good here strong support in this range....
Just a little churn today.
Biopsy News is coming
Dont worry I am working on getting you busted right now...
Green day again...Morning rookies have flipped...time to move higher..
Higher Healing.....
What are you going to say when Biopsy news comes out and sends this stock up 100 %
This stock went up 6% on a day when the Market got Slaughtered
Wise up !!!!
Boo hoo, poor track records here will be exposed...
CBIS going higher
Nothing personal, It's just you have been wrong since .02 and I'm just showing newbies your track record...
Grow some skin...
If PR comes out before the bell your little trade wont look so good.
Have you seen the Chart ? when Biopsy news hits CBIS will break the .24 mark from last week and keep on going right to .38 JMHO
dudes like him get all excited about turning a profit chump change...
But it takes a real Investor to make the Big daddy warbucks...
because they know the fundementals and a longer term outlook.
CBIS is going to .70 before the year is over Mark this post !!
Blah blah, everyday you come on here and say it will go down...even a broken clock is right 2 times a day...
You sold at .03 and come on here everyday to tell us its going down for 2 months now LOLOLOLOL
Have you checked the PPS lately lol
Just like you said at .03 that it will never get to .o9 lol who would even bother to listen to you after that call...lol
Give it up already lol at least Dark knew when to quit bashing lol.....
It was just a few day traders going flat at the end of the day, and it went down the last 15 min. on low volume.....
If Management wants to play this right they should release the news no later than next week. They must do it before the Chart starts breaking down...
Just a guess but I think we get Biopsy news On Friday ;]
420
CBIS is for real this is not a p&D like some bashers claim. This is a company that is the First to Release a MJ health product Line here in America and now yesterdays news with Europe Agreements and Licenses means this company is going world wide with a New and Wanted Product line..
They are also going to be releasing the Cancer killing extract product to California and a few other states soon...
BIOPSY news talk is big because it will VALIDATE their PRODUCTS.
CBIS will be .70 by summertime when everyone is Talking Legalization...forcing the Feds to rescheldule MMj opening up the floodgates for Cannabis science products.
.70 is coming Buy and Hold
I have since .02 ;]
Volume is strong to the upside...BIOPSY News is near. This stock is about to explode to .35 when news hits JMHO
sweet CBIS